Request Demo
Last update 20 Mar 2025
Human Growth Hormone (Zhongshan Sinobioway Hygene)
Last update 20 Mar 2025
Overview
Basic Info
Drug Type Biosimilar, Hormone |
Synonyms Recombinant Human Growth Hormone, Recombinant Human Growth Hormone for Injection(Zhongshan Sinobioway Hygene Biomedicine Co Ltd), 注射用重组人生长激素（中山未名海济生物医药） + [3] |
Target |
Action agonists |
Mechanism GHR agonists(Growth hormone receptor agonists) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date China (23 Mar 2005), |
Regulation- |
Login to view timeline
Structure/Sequence
Sequence Code 26401985
The sequence is quoted from: *****
Related
1
Clinical Trials associated with Human Growth Hormone (Zhongshan Sinobioway Hygene)CTR20210992
单中心、双周期、随机、盲法、自身交叉对照评价人生长激素注射液与注射用人生长激素在中国健康成年志愿者中单次给药的生物等效性研究
[Translation] A single-center, two-period, randomized, blinded, self-crossover controlled study to evaluate the bioequivalence of human growth hormone injection and human growth hormone for injection in healthy Chinese adult volunteers after single administration
100 Clinical Results associated with Human Growth Hormone (Zhongshan Sinobioway Hygene)
Login to view more data
100 Translational Medicine associated with Human Growth Hormone (Zhongshan Sinobioway Hygene)
Login to view more data
100 Patents (Medical) associated with Human Growth Hormone (Zhongshan Sinobioway Hygene)
Login to view more data
100 Deals associated with Human Growth Hormone (Zhongshan Sinobioway Hygene)
Login to view more data
R&D Status
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Growth Disorders | China | 23 Mar 2005 | |
| Growth hormone deficiency | China | 23 Mar 2005 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free